Pharma & Healthcare
Global Liraglutide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 01, 25
- ID: 285412
- Pages: 123
- Figures: 138
- Views: 36
In 2024, the global market size of Liraglutide was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
China Liraglutide market size was US$ million in 2024, while the US and Europe Liraglutide were US$ million and US$ million, severally. The proportion of the US was % in 2024, while China and Europe were % and % respectively, and it is predicted that China proportion will reach % in 2031, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Liraglutide landscape, Germany is projected to reach US$ million by 2031 trailing a CAGR of % over the forecast period.
The global key companies of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
In 2024, Pills segment accounted for a share of % in the global Liraglutide market. And this product segment is poised to reach US$ million by 2031 from US$ million in 2024.
In Liraglutide market, the Hospital segment holds an important share in terms of application, and it is expected to reach a revenue of US$ million by 2031, at a CAGR of % during 2025 and 2031.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liraglutide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liraglutide.
The Liraglutide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liraglutide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liraglutide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Segment by Type
Pills
Liquid
Segment by Application
Hospital
Drug Store
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liraglutide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Liraglutide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liraglutide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
China Liraglutide market size was US$ million in 2024, while the US and Europe Liraglutide were US$ million and US$ million, severally. The proportion of the US was % in 2024, while China and Europe were % and % respectively, and it is predicted that China proportion will reach % in 2031, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Liraglutide landscape, Germany is projected to reach US$ million by 2031 trailing a CAGR of % over the forecast period.
The global key companies of Liraglutide include HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide, AmbioPharm, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
In 2024, Pills segment accounted for a share of % in the global Liraglutide market. And this product segment is poised to reach US$ million by 2031 from US$ million in 2024.
In Liraglutide market, the Hospital segment holds an important share in terms of application, and it is expected to reach a revenue of US$ million by 2031, at a CAGR of % during 2025 and 2031.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Liraglutide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liraglutide.
The Liraglutide market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liraglutide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liraglutide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.
By Company
HEC Pharm
Bachem
Bharat Pharmaceuticals
Kingpep Biotechnology
Shenzhen JYMed Technology
Wuxi Asiapeptide
AmbioPharm
Segment by Type
Pills
Liquid
Segment by Application
Hospital
Drug Store
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liraglutide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Liraglutide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liraglutide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
1 Study Coverage
1.1 Liraglutide Product Introduction
1.2 Market by Type
1.2.1 Global Liraglutide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Pills
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Liraglutide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liraglutide Market Size Estimates and Forecasts
2.1.1 Global Liraglutide Revenue 2020-2031
2.1.2 Global Liraglutide Sales 2020-2031
2.2 Liraglutide Market Size by Region: 2024 Versus 2031
2.3 Liraglutide Sales by Region (2020-2031)
2.3.1 Global Liraglutide Sales by Region: 2020-2025
2.3.2 Global Liraglutide Sales Forecast by Region (2026-2031)
2.3.3 Global Liraglutide Sales Market Share by Region (2020-2031)
2.4 Liraglutide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Liraglutide Revenue by Region: 2020-2025
2.4.2 Global Liraglutide Revenue Forecast by Region (2026-2031)
2.4.3 Global Liraglutide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Liraglutide Sales by Type (2020-2031)
3.1.1.1 Global Liraglutide Sales Volume by Type (2020-2031)
3.1.1.2 Global Liraglutide Sales Market Share by Type (2020-2031)
3.1.2 Global Liraglutide Revenue by Type (2020-2031)
3.1.2.1 Global Liraglutide Revenue by Type (2020-2031)
3.1.2.2 Global Liraglutide Revenue Market Share by Type (2020-2031)
3.1.3 Liraglutide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Liraglutide Sales by Application (2020-2031)
3.2.1.1 Global Liraglutide Sales Volume by Application (2020-2031)
3.2.1.2 Global Liraglutide Sales Market Share by Application (2020-2031)
3.2.2 Global Liraglutide Revenue by Application (2020-2031)
3.2.2.1 Global Liraglutide Revenue by Application (2020-2031)
3.2.2.2 Global Liraglutide Revenue Market Share by Application (2020-2031)
3.2.3 Liraglutide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Pills of Liraglutide Revenue Market Share by Application
3.3.2 Liquid of Liraglutide Revenue Market Share by Application
4 Global Liraglutide by Manufacturers
4.1 Global Top Liraglutide Manufacturers by Sales (2020-2025)
4.1.1 Global Liraglutide Sales by Manufacturer (2020-2025)
4.1.2 Global Liraglutide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Liraglutide Manufacturers by Revenue (2020-2025)
4.2.1 Global Liraglutide Revenue by Manufacturer (2020-2025)
4.2.2 Global Liraglutide Revenue Share by Manufacturer (2020-2025)
4.3 Global Liraglutide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Liraglutide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Liraglutide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Liraglutide Manufacturing Base Distribution, Product Type
4.5.1 Liraglutide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Liraglutide Market
4.5.3 Manufacturers Liraglutide Product Type and Application
4.5.4 Pills Market Sales of Liraglutide by Manufacturer
4.5.5 Liquid Market Sales of Liraglutide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 HEC Pharm
5.1.1 HEC Pharm Company Information
5.1.2 HEC Pharm Description, Business Overview
5.1.3 HEC Pharm Liraglutide Products Offered
5.1.4 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 HEC Pharm Liraglutide Sales by Product in 2024
5.1.6 HEC Pharm Liraglutide Sales by Application in 2024
5.1.7 HEC Pharm Liraglutide Sales by Geographic Area in 2024
5.1.8 HEC Pharm Recent Developments
5.2 Bachem
5.2.1 Bachem Company Information
5.2.2 Bachem Description, Business Overview
5.2.3 Bachem Liraglutide Products Offered
5.2.4 Bachem Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Bachem Liraglutide Sales by Product in 2024
5.2.6 Bachem Liraglutide Sales by Application in 2024
5.2.7 Bachem Liraglutide Sales by Geographic Area in 2024
5.2.8 Bachem Recent Developments
5.3 Bharat Pharmaceuticals
5.3.1 Bharat Pharmaceuticals Company Information
5.3.2 Bharat Pharmaceuticals Description, Business Overview
5.3.3 Bharat Pharmaceuticals Liraglutide Products Offered
5.3.4 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Bharat Pharmaceuticals Liraglutide Sales by Product in 2024
5.3.6 Bharat Pharmaceuticals Liraglutide Sales by Application in 2024
5.3.7 Bharat Pharmaceuticals Liraglutide Sales by Geographic Area in 2024
5.3.8 Bharat Pharmaceuticals Recent Developments
5.4 Kingpep Biotechnology
5.4.1 Kingpep Biotechnology Company Information
5.4.2 Kingpep Biotechnology Description, Business Overview
5.4.3 Kingpep Biotechnology Liraglutide Products Offered
5.4.4 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Kingpep Biotechnology Liraglutide Sales by Product in 2024
5.4.6 Kingpep Biotechnology Liraglutide Sales by Application in 2024
5.4.7 Kingpep Biotechnology Liraglutide Sales by Geographic Area in 2024
5.4.8 Kingpep Biotechnology Recent Developments
5.5 Shenzhen JYMed Technology
5.5.1 Shenzhen JYMed Technology Company Information
5.5.2 Shenzhen JYMed Technology Description, Business Overview
5.5.3 Shenzhen JYMed Technology Liraglutide Products Offered
5.5.4 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Shenzhen JYMed Technology Liraglutide Sales by Product in 2024
5.5.6 Shenzhen JYMed Technology Liraglutide Sales by Application in 2024
5.5.7 Shenzhen JYMed Technology Liraglutide Sales by Geographic Area in 2024
5.5.8 Shenzhen JYMed Technology Recent Developments
5.6 Wuxi Asiapeptide
5.6.1 Wuxi Asiapeptide Company Information
5.6.2 Wuxi Asiapeptide Description, Business Overview
5.6.3 Wuxi Asiapeptide Liraglutide Products Offered
5.6.4 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Wuxi Asiapeptide Liraglutide Sales by Product in 2024
5.6.6 Wuxi Asiapeptide Liraglutide Sales by Application in 2024
5.6.7 Wuxi Asiapeptide Liraglutide Sales by Geographic Area in 2024
5.6.8 Wuxi Asiapeptide Recent Developments
5.7 AmbioPharm
5.7.1 AmbioPharm Company Information
5.7.2 AmbioPharm Description, Business Overview
5.7.3 AmbioPharm Liraglutide Products Offered
5.7.4 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.7.5 AmbioPharm Liraglutide Sales by Product in 2024
5.7.6 AmbioPharm Liraglutide Sales by Application in 2024
5.7.7 AmbioPharm Liraglutide Sales by Geographic Area in 2024
5.7.8 AmbioPharm Recent Developments
6 North America
6.1 North America Liraglutide Market Size YoY Growth 2020-2031
6.2 North America Liraglutide Market Facts & Figures by Country
6.2.1 North America Liraglutide Sales by Country (2020-2031)
6.2.2 North America Liraglutide Revenue by Country (2020-2031)
6.3 North America Liraglutide Sales by Type (2020-2025)
6.4 North America Liraglutide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Liraglutide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Liraglutide Market Facts & Figures by Region
7.2.1 Asia-Pacific Liraglutide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Liraglutide Revenue by Region (2020-2031)
7.3 Asia-Pacific Liraglutide Sales by Type (2020-2025)
7.4 Asia-Pacific Liraglutide Sales by Application (2020-2025)
8 Europe
8.1 Europe Liraglutide Market Size YoY Growth 2020-2031
8.2 Europe Liraglutide Market Facts & Figures by Country
8.2.1 Europe Liraglutide Sales by Country (2020-2031)
8.2.2 Europe Liraglutide Revenue by Country (2020-2031)
8.3 Europe Liraglutide Sales by Type (2020-2025)
8.4 Europe Liraglutide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Liraglutide Market Size YoY Growth 2020-2031
9.2 Latin America Liraglutide Market Facts & Figures by Country
9.2.1 Latin America Liraglutide Sales by Country (2020-2031)
9.2.2 Latin America Liraglutide Revenue by Country (2020-2031)
9.3 Latin America Liraglutide Sales by Type (2020-2025)
9.4 Latin America Liraglutide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Liraglutide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Liraglutide Market Facts & Figures by Country
10.2.1 Middle East and Africa Liraglutide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Liraglutide Revenue by Country (2020-2031)
10.3 Middle East and Africa Liraglutide Sales by Type (2020-2025)
10.4 Middle East and Africa Liraglutide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Liraglutide Supply Chain Analysis
11.2 Liraglutide Key Raw Materials and Upstream Suppliers
11.3 Liraglutide Clients Analysis
11.4 Liraglutide Sales Channel and Sales Model Analysis
11.4.1 Liraglutide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Liraglutide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Liraglutide Distributors
12 Liraglutide Market Dynamics
12.1 Liraglutide Industry Trends
12.2 Liraglutide Market Drivers
12.3 Liraglutide Market Challenges
12.4 Liraglutide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Liraglutide Product Introduction
1.2 Market by Type
1.2.1 Global Liraglutide Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Pills
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Liraglutide Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liraglutide Market Size Estimates and Forecasts
2.1.1 Global Liraglutide Revenue 2020-2031
2.1.2 Global Liraglutide Sales 2020-2031
2.2 Liraglutide Market Size by Region: 2024 Versus 2031
2.3 Liraglutide Sales by Region (2020-2031)
2.3.1 Global Liraglutide Sales by Region: 2020-2025
2.3.2 Global Liraglutide Sales Forecast by Region (2026-2031)
2.3.3 Global Liraglutide Sales Market Share by Region (2020-2031)
2.4 Liraglutide Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Liraglutide Revenue by Region: 2020-2025
2.4.2 Global Liraglutide Revenue Forecast by Region (2026-2031)
2.4.3 Global Liraglutide Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Liraglutide Sales by Type (2020-2031)
3.1.1.1 Global Liraglutide Sales Volume by Type (2020-2031)
3.1.1.2 Global Liraglutide Sales Market Share by Type (2020-2031)
3.1.2 Global Liraglutide Revenue by Type (2020-2031)
3.1.2.1 Global Liraglutide Revenue by Type (2020-2031)
3.1.2.2 Global Liraglutide Revenue Market Share by Type (2020-2031)
3.1.3 Liraglutide Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Liraglutide Sales by Application (2020-2031)
3.2.1.1 Global Liraglutide Sales Volume by Application (2020-2031)
3.2.1.2 Global Liraglutide Sales Market Share by Application (2020-2031)
3.2.2 Global Liraglutide Revenue by Application (2020-2031)
3.2.2.1 Global Liraglutide Revenue by Application (2020-2031)
3.2.2.2 Global Liraglutide Revenue Market Share by Application (2020-2031)
3.2.3 Liraglutide Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Pills of Liraglutide Revenue Market Share by Application
3.3.2 Liquid of Liraglutide Revenue Market Share by Application
4 Global Liraglutide by Manufacturers
4.1 Global Top Liraglutide Manufacturers by Sales (2020-2025)
4.1.1 Global Liraglutide Sales by Manufacturer (2020-2025)
4.1.2 Global Liraglutide Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Liraglutide Manufacturers by Revenue (2020-2025)
4.2.1 Global Liraglutide Revenue by Manufacturer (2020-2025)
4.2.2 Global Liraglutide Revenue Share by Manufacturer (2020-2025)
4.3 Global Liraglutide Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Liraglutide Manufacturers Covered: Ranking by Revenue
4.4.2 Global Liraglutide Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Liraglutide Manufacturing Base Distribution, Product Type
4.5.1 Liraglutide Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Liraglutide Market
4.5.3 Manufacturers Liraglutide Product Type and Application
4.5.4 Pills Market Sales of Liraglutide by Manufacturer
4.5.5 Liquid Market Sales of Liraglutide by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 HEC Pharm
5.1.1 HEC Pharm Company Information
5.1.2 HEC Pharm Description, Business Overview
5.1.3 HEC Pharm Liraglutide Products Offered
5.1.4 HEC Pharm Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.1.5 HEC Pharm Liraglutide Sales by Product in 2024
5.1.6 HEC Pharm Liraglutide Sales by Application in 2024
5.1.7 HEC Pharm Liraglutide Sales by Geographic Area in 2024
5.1.8 HEC Pharm Recent Developments
5.2 Bachem
5.2.1 Bachem Company Information
5.2.2 Bachem Description, Business Overview
5.2.3 Bachem Liraglutide Products Offered
5.2.4 Bachem Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Bachem Liraglutide Sales by Product in 2024
5.2.6 Bachem Liraglutide Sales by Application in 2024
5.2.7 Bachem Liraglutide Sales by Geographic Area in 2024
5.2.8 Bachem Recent Developments
5.3 Bharat Pharmaceuticals
5.3.1 Bharat Pharmaceuticals Company Information
5.3.2 Bharat Pharmaceuticals Description, Business Overview
5.3.3 Bharat Pharmaceuticals Liraglutide Products Offered
5.3.4 Bharat Pharmaceuticals Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Bharat Pharmaceuticals Liraglutide Sales by Product in 2024
5.3.6 Bharat Pharmaceuticals Liraglutide Sales by Application in 2024
5.3.7 Bharat Pharmaceuticals Liraglutide Sales by Geographic Area in 2024
5.3.8 Bharat Pharmaceuticals Recent Developments
5.4 Kingpep Biotechnology
5.4.1 Kingpep Biotechnology Company Information
5.4.2 Kingpep Biotechnology Description, Business Overview
5.4.3 Kingpep Biotechnology Liraglutide Products Offered
5.4.4 Kingpep Biotechnology Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Kingpep Biotechnology Liraglutide Sales by Product in 2024
5.4.6 Kingpep Biotechnology Liraglutide Sales by Application in 2024
5.4.7 Kingpep Biotechnology Liraglutide Sales by Geographic Area in 2024
5.4.8 Kingpep Biotechnology Recent Developments
5.5 Shenzhen JYMed Technology
5.5.1 Shenzhen JYMed Technology Company Information
5.5.2 Shenzhen JYMed Technology Description, Business Overview
5.5.3 Shenzhen JYMed Technology Liraglutide Products Offered
5.5.4 Shenzhen JYMed Technology Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Shenzhen JYMed Technology Liraglutide Sales by Product in 2024
5.5.6 Shenzhen JYMed Technology Liraglutide Sales by Application in 2024
5.5.7 Shenzhen JYMed Technology Liraglutide Sales by Geographic Area in 2024
5.5.8 Shenzhen JYMed Technology Recent Developments
5.6 Wuxi Asiapeptide
5.6.1 Wuxi Asiapeptide Company Information
5.6.2 Wuxi Asiapeptide Description, Business Overview
5.6.3 Wuxi Asiapeptide Liraglutide Products Offered
5.6.4 Wuxi Asiapeptide Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Wuxi Asiapeptide Liraglutide Sales by Product in 2024
5.6.6 Wuxi Asiapeptide Liraglutide Sales by Application in 2024
5.6.7 Wuxi Asiapeptide Liraglutide Sales by Geographic Area in 2024
5.6.8 Wuxi Asiapeptide Recent Developments
5.7 AmbioPharm
5.7.1 AmbioPharm Company Information
5.7.2 AmbioPharm Description, Business Overview
5.7.3 AmbioPharm Liraglutide Products Offered
5.7.4 AmbioPharm Liraglutide Sales, Revenue and Gross Margin (2020-2025)
5.7.5 AmbioPharm Liraglutide Sales by Product in 2024
5.7.6 AmbioPharm Liraglutide Sales by Application in 2024
5.7.7 AmbioPharm Liraglutide Sales by Geographic Area in 2024
5.7.8 AmbioPharm Recent Developments
6 North America
6.1 North America Liraglutide Market Size YoY Growth 2020-2031
6.2 North America Liraglutide Market Facts & Figures by Country
6.2.1 North America Liraglutide Sales by Country (2020-2031)
6.2.2 North America Liraglutide Revenue by Country (2020-2031)
6.3 North America Liraglutide Sales by Type (2020-2025)
6.4 North America Liraglutide Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Liraglutide Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Liraglutide Market Facts & Figures by Region
7.2.1 Asia-Pacific Liraglutide Sales by Region (2020-2031)
7.2.2 Asia-Pacific Liraglutide Revenue by Region (2020-2031)
7.3 Asia-Pacific Liraglutide Sales by Type (2020-2025)
7.4 Asia-Pacific Liraglutide Sales by Application (2020-2025)
8 Europe
8.1 Europe Liraglutide Market Size YoY Growth 2020-2031
8.2 Europe Liraglutide Market Facts & Figures by Country
8.2.1 Europe Liraglutide Sales by Country (2020-2031)
8.2.2 Europe Liraglutide Revenue by Country (2020-2031)
8.3 Europe Liraglutide Sales by Type (2020-2025)
8.4 Europe Liraglutide Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Liraglutide Market Size YoY Growth 2020-2031
9.2 Latin America Liraglutide Market Facts & Figures by Country
9.2.1 Latin America Liraglutide Sales by Country (2020-2031)
9.2.2 Latin America Liraglutide Revenue by Country (2020-2031)
9.3 Latin America Liraglutide Sales by Type (2020-2025)
9.4 Latin America Liraglutide Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Liraglutide Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Liraglutide Market Facts & Figures by Country
10.2.1 Middle East and Africa Liraglutide Sales by Country (2020-2031)
10.2.2 Middle East and Africa Liraglutide Revenue by Country (2020-2031)
10.3 Middle East and Africa Liraglutide Sales by Type (2020-2025)
10.4 Middle East and Africa Liraglutide Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Liraglutide Supply Chain Analysis
11.2 Liraglutide Key Raw Materials and Upstream Suppliers
11.3 Liraglutide Clients Analysis
11.4 Liraglutide Sales Channel and Sales Model Analysis
11.4.1 Liraglutide Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Liraglutide Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Liraglutide Distributors
12 Liraglutide Market Dynamics
12.1 Liraglutide Industry Trends
12.2 Liraglutide Market Drivers
12.3 Liraglutide Market Challenges
12.4 Liraglutide Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Liraglutide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Liraglutide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Liraglutide Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Liraglutide Sales by Region (2020-2025) & (K MT)
Table 5. Global Liraglutide Sales Forecast by Region (2026-2031) & (K MT)
Table 6. Global Liraglutide Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Liraglutide Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Liraglutide Sales Volume by Type (2020-2025) & (K MT)
Table 9. Global Liraglutide Sales Volume by Type (2026-2031) & (K MT)
Table 10. Global Liraglutide Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Liraglutide Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Liraglutide Sales Volume by Application (2020-2025) & (K MT)
Table 13. Global Liraglutide Sales Volume by Application (2026-2031) & (K MT)
Table 14. Global Liraglutide Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Liraglutide Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Liraglutide Sales by Manufacturer (2020-2025) & (K MT)
Table 17. Global Liraglutide Sales Share by Manufacturer (2020-2025)
Table 18. Liraglutide Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Liraglutide Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Liraglutide Price (2020-2025) & (USD/MT)
Table 21. Ranking of Global Top Liraglutide Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Liraglutide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2024)
Table 24. Liraglutide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Liraglutide Market
Table 26. Manufacturers Liraglutide Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. HEC Pharm Company Information
Table 29. HEC Pharm Description and Business Overview
Table 30. HEC Pharm Liraglutide Product
Table 31. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 32. HEC Pharm Sales Proportion of Liraglutide by Product in 2024
Table 33. HEC Pharm Sales Proportion of Liraglutide by Application in 2024
Table 34. HEC Pharm Sales Proportion of Liraglutide by Geographic Area in 2024
Table 35. HEC Pharm Recent Developments
Table 36. Bachem Company Information
Table 37. Bachem Description and Business Overview
Table 38. Bachem Liraglutide Product
Table 39. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 40. Bachem Sales Proportion of Liraglutide by Product in 2024
Table 41. Bachem Sales Proportion of Liraglutide by Application in 2024
Table 42. Bachem Sales Proportion of Liraglutide by Geographic Area in 2024
Table 43. Bachem Recent Developments
Table 44. Bharat Pharmaceuticals Company Information
Table 45. Bharat Pharmaceuticals Description and Business Overview
Table 46. Bharat Pharmaceuticals Liraglutide Product
Table 47. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 48. Bharat Pharmaceuticals Sales Proportion of Liraglutide by Product in 2024
Table 49. Bharat Pharmaceuticals Sales Proportion of Liraglutide by Application in 2024
Table 50. Bharat Pharmaceuticals Sales Proportion of Liraglutide by Geographic Area in 2024
Table 51. Bharat Pharmaceuticals Recent Developments
Table 52. Kingpep Biotechnology Company Information
Table 53. Kingpep Biotechnology Description and Business Overview
Table 54. Kingpep Biotechnology Liraglutide Product
Table 55. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. Kingpep Biotechnology Sales Proportion of Liraglutide by Product in 2024
Table 57. Kingpep Biotechnology Sales Proportion of Liraglutide by Application in 2024
Table 58. Kingpep Biotechnology Sales Proportion of Liraglutide by Geographic Area in 2024
Table 59. Kingpep Biotechnology Recent Developments
Table 60. Shenzhen JYMed Technology Company Information
Table 61. Shenzhen JYMed Technology Description and Business Overview
Table 62. Shenzhen JYMed Technology Liraglutide Product
Table 63. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Shenzhen JYMed Technology Sales Proportion of Liraglutide by Product in 2024
Table 65. Shenzhen JYMed Technology Sales Proportion of Liraglutide by Application in 2024
Table 66. Shenzhen JYMed Technology Sales Proportion of Liraglutide by Geographic Area in 2024
Table 67. Shenzhen JYMed Technology Recent Developments
Table 68. Wuxi Asiapeptide Company Information
Table 69. Wuxi Asiapeptide Description and Business Overview
Table 70. Wuxi Asiapeptide Liraglutide Product
Table 71. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 72. Wuxi Asiapeptide Sales Proportion of Liraglutide by Product in 2024
Table 73. Wuxi Asiapeptide Sales Proportion of Liraglutide by Application in 2024
Table 74. Wuxi Asiapeptide Sales Proportion of Liraglutide by Geographic Area in 2024
Table 75. Wuxi Asiapeptide Recent Developments
Table 76. AmbioPharm Company Information
Table 77. AmbioPharm Description and Business Overview
Table 78. AmbioPharm Liraglutide Product
Table 79. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. AmbioPharm Sales Proportion of Liraglutide by Product in 2024
Table 81. AmbioPharm Sales Proportion of Liraglutide by Application in 2024
Table 82. AmbioPharm Sales Proportion of Liraglutide by Geographic Area in 2024
Table 83. AmbioPharm Recent Developments
Table 84. North America Liraglutide Sales by Country (2020-2025) & (K MT)
Table 85. North America Liraglutide Sales by Country (2026-2031) & (K MT)
Table 86. North America Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 87. North America Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 88. North America Liraglutide Sales by Type (2020-2025) & (K MT)
Table 89. North America Liraglutide Sales by Application (2020-2025) & (K MT)
Table 90. Asia-Pacific Liraglutide Sales by Region (2020-2025) & (K MT)
Table 91. Asia-Pacific Liraglutide Sales by Region (2026-2031) & (K MT)
Table 92. Asia-Pacific Liraglutide Revenue by Region (2020-2025) & (US$ Million)
Table 93. Asia-Pacific Liraglutide Revenue by Region (2026-2031) & (US$ Million)
Table 94. Asia-Pacific Liraglutide Sales by Type (2020-2025) & (K MT)
Table 95. Asia-Pacific Liraglutide Sales by Application (2020-2025) & (K MT)
Table 96. Europe Liraglutide Sales by Country (2020-2025) & (K MT)
Table 97. Europe Liraglutide Sales by Country (2026-2031) & (K MT)
Table 98. Europe Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 99. Europe Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 100. Europe Liraglutide Sales by Type (2020-2025) & (K MT)
Table 101. Europe Liraglutide Sales by Application (2020-2025) & (K MT)
Table 102. Latin America Liraglutide Sales by Country (2020-2025) & (K MT)
Table 103. Latin America Liraglutide Sales by Country (2026-2031) & (K MT)
Table 104. Latin America Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 105. Latin America Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 106. Latin America Liraglutide Sales by Type (2020-2025) & (K MT)
Table 107. Latin America Liraglutide Sales by Application (2020-2025) & (K MT)
Table 108. Middle East and Africa Liraglutide Sales by Country (2020-2025) & (K MT)
Table 109. Middle East and Africa Liraglutide Sales by Country (2026-2031) & (K MT)
Table 110. Middle East and Africa Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 111. Middle East and Africa Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 112. Middle East and Africa Liraglutide Sales by Type (2020-2025) & (K MT)
Table 113. Middle East and Africa Liraglutide Sales by Application (2020-2025) & (K MT)
Table 114. Liraglutide Key Raw Materials, Industry Status and Trend
Table 115. Liraglutide Key Raw Materials and Upstream Suppliers
Table 116. Liraglutide Clients Status and Trend
Table 117. Liraglutide Typical Clients
Table 118. Liraglutide Distributors
Table 119. Liraglutide Market Trends
Table 120. Liraglutide Market Drivers
Table 121. Liraglutide Market Challenges
Table 122. Liraglutide Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Liraglutide Sales Market Share by Type in 2024 & 2031
Figure 4. Pills Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Liraglutide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Liraglutide Sales Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Liraglutide Report Years Considered
Figure 11. Global Liraglutide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Liraglutide Market Size 2020-2031 (US$ Million)
Figure 13. Global Liraglutide Sales 2020-2031 (K MT)
Figure 14. Global Liraglutide Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Liraglutide Revenue Market Share by Region (2020-2031)
Figure 16. Global Liraglutide Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Liraglutide Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Liraglutide Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)
Figure 19. Global Liraglutide Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Liraglutide Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Liraglutide Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)
Figure 22. Pills of Liraglutide Revenue Market Share by Application, 2024 VS 2031
Figure 23. Liquid of Liraglutide Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Liraglutide Sales Share by Manufacturer in 2024
Figure 25. Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Pills Market Sales Proportion by Manufacturer in 2024
Figure 27. Liquid Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Liraglutide Revenue 2020-2031 (US$ Million)
Figure 29. North America Liraglutide Sales Market Share by Type (2020-2025)
Figure 30. North America Liraglutide Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Liraglutide Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Liraglutide Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Liraglutide Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Liraglutide Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Liraglutide Sales Market Share by Application (2020-2025)
Figure 36. Europe Liraglutide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Liraglutide Sales Market Share by Country (2020-2031)
Figure 38. Europe Liraglutide Revenue Market Share by Country (2020-2031)
Figure 39. Europe Liraglutide Sales Market Share by Type (2020-2025)
Figure 40. Europe Liraglutide Sales Market Share by Application (2020-2025)
Figure 41. Latin America Liraglutide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Liraglutide Sales Market Share by Country (2020-2031)
Figure 43. Latin America Liraglutide Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Liraglutide Sales Market Share by Type (2020-2025)
Figure 45. Latin America Liraglutide Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Liraglutide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Liraglutide Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Liraglutide Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Liraglutide Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Liraglutide Sales Market Share by Application (2020-2025)
Figure 51. Liraglutide Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Liraglutide Raw Materials by Region in 2024
Figure 53. Liraglutide Distribution Channels
Figure 54. Global Liraglutide Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Liraglutide Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Table 1. Global Liraglutide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Liraglutide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Liraglutide Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Liraglutide Sales by Region (2020-2025) & (K MT)
Table 5. Global Liraglutide Sales Forecast by Region (2026-2031) & (K MT)
Table 6. Global Liraglutide Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Liraglutide Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Liraglutide Sales Volume by Type (2020-2025) & (K MT)
Table 9. Global Liraglutide Sales Volume by Type (2026-2031) & (K MT)
Table 10. Global Liraglutide Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Liraglutide Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Liraglutide Sales Volume by Application (2020-2025) & (K MT)
Table 13. Global Liraglutide Sales Volume by Application (2026-2031) & (K MT)
Table 14. Global Liraglutide Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Liraglutide Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Liraglutide Sales by Manufacturer (2020-2025) & (K MT)
Table 17. Global Liraglutide Sales Share by Manufacturer (2020-2025)
Table 18. Liraglutide Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Liraglutide Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Liraglutide Price (2020-2025) & (USD/MT)
Table 21. Ranking of Global Top Liraglutide Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Liraglutide Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Liraglutide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liraglutide as of 2024)
Table 24. Liraglutide Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Liraglutide Market
Table 26. Manufacturers Liraglutide Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. HEC Pharm Company Information
Table 29. HEC Pharm Description and Business Overview
Table 30. HEC Pharm Liraglutide Product
Table 31. HEC Pharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 32. HEC Pharm Sales Proportion of Liraglutide by Product in 2024
Table 33. HEC Pharm Sales Proportion of Liraglutide by Application in 2024
Table 34. HEC Pharm Sales Proportion of Liraglutide by Geographic Area in 2024
Table 35. HEC Pharm Recent Developments
Table 36. Bachem Company Information
Table 37. Bachem Description and Business Overview
Table 38. Bachem Liraglutide Product
Table 39. Bachem Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 40. Bachem Sales Proportion of Liraglutide by Product in 2024
Table 41. Bachem Sales Proportion of Liraglutide by Application in 2024
Table 42. Bachem Sales Proportion of Liraglutide by Geographic Area in 2024
Table 43. Bachem Recent Developments
Table 44. Bharat Pharmaceuticals Company Information
Table 45. Bharat Pharmaceuticals Description and Business Overview
Table 46. Bharat Pharmaceuticals Liraglutide Product
Table 47. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 48. Bharat Pharmaceuticals Sales Proportion of Liraglutide by Product in 2024
Table 49. Bharat Pharmaceuticals Sales Proportion of Liraglutide by Application in 2024
Table 50. Bharat Pharmaceuticals Sales Proportion of Liraglutide by Geographic Area in 2024
Table 51. Bharat Pharmaceuticals Recent Developments
Table 52. Kingpep Biotechnology Company Information
Table 53. Kingpep Biotechnology Description and Business Overview
Table 54. Kingpep Biotechnology Liraglutide Product
Table 55. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. Kingpep Biotechnology Sales Proportion of Liraglutide by Product in 2024
Table 57. Kingpep Biotechnology Sales Proportion of Liraglutide by Application in 2024
Table 58. Kingpep Biotechnology Sales Proportion of Liraglutide by Geographic Area in 2024
Table 59. Kingpep Biotechnology Recent Developments
Table 60. Shenzhen JYMed Technology Company Information
Table 61. Shenzhen JYMed Technology Description and Business Overview
Table 62. Shenzhen JYMed Technology Liraglutide Product
Table 63. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Shenzhen JYMed Technology Sales Proportion of Liraglutide by Product in 2024
Table 65. Shenzhen JYMed Technology Sales Proportion of Liraglutide by Application in 2024
Table 66. Shenzhen JYMed Technology Sales Proportion of Liraglutide by Geographic Area in 2024
Table 67. Shenzhen JYMed Technology Recent Developments
Table 68. Wuxi Asiapeptide Company Information
Table 69. Wuxi Asiapeptide Description and Business Overview
Table 70. Wuxi Asiapeptide Liraglutide Product
Table 71. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 72. Wuxi Asiapeptide Sales Proportion of Liraglutide by Product in 2024
Table 73. Wuxi Asiapeptide Sales Proportion of Liraglutide by Application in 2024
Table 74. Wuxi Asiapeptide Sales Proportion of Liraglutide by Geographic Area in 2024
Table 75. Wuxi Asiapeptide Recent Developments
Table 76. AmbioPharm Company Information
Table 77. AmbioPharm Description and Business Overview
Table 78. AmbioPharm Liraglutide Product
Table 79. AmbioPharm Liraglutide Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. AmbioPharm Sales Proportion of Liraglutide by Product in 2024
Table 81. AmbioPharm Sales Proportion of Liraglutide by Application in 2024
Table 82. AmbioPharm Sales Proportion of Liraglutide by Geographic Area in 2024
Table 83. AmbioPharm Recent Developments
Table 84. North America Liraglutide Sales by Country (2020-2025) & (K MT)
Table 85. North America Liraglutide Sales by Country (2026-2031) & (K MT)
Table 86. North America Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 87. North America Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 88. North America Liraglutide Sales by Type (2020-2025) & (K MT)
Table 89. North America Liraglutide Sales by Application (2020-2025) & (K MT)
Table 90. Asia-Pacific Liraglutide Sales by Region (2020-2025) & (K MT)
Table 91. Asia-Pacific Liraglutide Sales by Region (2026-2031) & (K MT)
Table 92. Asia-Pacific Liraglutide Revenue by Region (2020-2025) & (US$ Million)
Table 93. Asia-Pacific Liraglutide Revenue by Region (2026-2031) & (US$ Million)
Table 94. Asia-Pacific Liraglutide Sales by Type (2020-2025) & (K MT)
Table 95. Asia-Pacific Liraglutide Sales by Application (2020-2025) & (K MT)
Table 96. Europe Liraglutide Sales by Country (2020-2025) & (K MT)
Table 97. Europe Liraglutide Sales by Country (2026-2031) & (K MT)
Table 98. Europe Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 99. Europe Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 100. Europe Liraglutide Sales by Type (2020-2025) & (K MT)
Table 101. Europe Liraglutide Sales by Application (2020-2025) & (K MT)
Table 102. Latin America Liraglutide Sales by Country (2020-2025) & (K MT)
Table 103. Latin America Liraglutide Sales by Country (2026-2031) & (K MT)
Table 104. Latin America Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 105. Latin America Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 106. Latin America Liraglutide Sales by Type (2020-2025) & (K MT)
Table 107. Latin America Liraglutide Sales by Application (2020-2025) & (K MT)
Table 108. Middle East and Africa Liraglutide Sales by Country (2020-2025) & (K MT)
Table 109. Middle East and Africa Liraglutide Sales by Country (2026-2031) & (K MT)
Table 110. Middle East and Africa Liraglutide Revenue by Country (2020-2025) & (US$ Million)
Table 111. Middle East and Africa Liraglutide Revenue by Country (2026-2031) & (US$ Million)
Table 112. Middle East and Africa Liraglutide Sales by Type (2020-2025) & (K MT)
Table 113. Middle East and Africa Liraglutide Sales by Application (2020-2025) & (K MT)
Table 114. Liraglutide Key Raw Materials, Industry Status and Trend
Table 115. Liraglutide Key Raw Materials and Upstream Suppliers
Table 116. Liraglutide Clients Status and Trend
Table 117. Liraglutide Typical Clients
Table 118. Liraglutide Distributors
Table 119. Liraglutide Market Trends
Table 120. Liraglutide Market Drivers
Table 121. Liraglutide Market Challenges
Table 122. Liraglutide Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Liraglutide Product Picture
Figure 2. Global Liraglutide Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Liraglutide Sales Market Share by Type in 2024 & 2031
Figure 4. Pills Product Picture
Figure 5. Liquid Product Picture
Figure 6. Global Liraglutide Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 7. Global Liraglutide Sales Market Share by Application in 2024 & 2031
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Liraglutide Report Years Considered
Figure 11. Global Liraglutide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Liraglutide Market Size 2020-2031 (US$ Million)
Figure 13. Global Liraglutide Sales 2020-2031 (K MT)
Figure 14. Global Liraglutide Sales Market Share Forecast by Region (2020-2031)
Figure 15. Global Liraglutide Revenue Market Share by Region (2020-2031)
Figure 16. Global Liraglutide Sales Market Share Forecast by Type (2020-2031)
Figure 17. Global Liraglutide Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Liraglutide Average Selling Price (ASP) by Type (2020-2025) & (USD/MT)
Figure 19. Global Liraglutide Sales Market Share Forecast by Application (2020-2031)
Figure 20. Global Liraglutide Revenue Market Share Forecast by Application (2020-2031)
Figure 21. Liraglutide Average Selling Price (ASP) by Application (2020-2025) & (USD/MT)
Figure 22. Pills of Liraglutide Revenue Market Share by Application, 2024 VS 2031
Figure 23. Liquid of Liraglutide Revenue Market Share by Application, 2024 VS 2031
Figure 24. Global Liraglutide Sales Share by Manufacturer in 2024
Figure 25. Liraglutide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Pills Market Sales Proportion by Manufacturer in 2024
Figure 27. Liquid Market Sales Proportion by Manufacturer in 2024
Figure 28. North America Liraglutide Revenue 2020-2031 (US$ Million)
Figure 29. North America Liraglutide Sales Market Share by Type (2020-2025)
Figure 30. North America Liraglutide Sales Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Liraglutide Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Liraglutide Sales Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Liraglutide Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Liraglutide Sales Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Liraglutide Sales Market Share by Application (2020-2025)
Figure 36. Europe Liraglutide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Liraglutide Sales Market Share by Country (2020-2031)
Figure 38. Europe Liraglutide Revenue Market Share by Country (2020-2031)
Figure 39. Europe Liraglutide Sales Market Share by Type (2020-2025)
Figure 40. Europe Liraglutide Sales Market Share by Application (2020-2025)
Figure 41. Latin America Liraglutide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Latin America Liraglutide Sales Market Share by Country (2020-2031)
Figure 43. Latin America Liraglutide Revenue Market Share by Country (2020-2025)
Figure 44. Latin America Liraglutide Sales Market Share by Type (2020-2025)
Figure 45. Latin America Liraglutide Sales Market Share by Application (2020-2025)
Figure 46. Middle East and Africa Liraglutide Revenue Growth Rate 2020-2031 (US$ Million)
Figure 47. Middle East and Africa Liraglutide Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Liraglutide Revenue Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Liraglutide Sales Market Share by Type (2020-2025)
Figure 50. Middle East and Africa Liraglutide Sales Market Share by Application (2020-2025)
Figure 51. Liraglutide Supply Chain (Upstream and Downstream Market)
Figure 52. Global Production Market Share of Liraglutide Raw Materials by Region in 2024
Figure 53. Liraglutide Distribution Channels
Figure 54. Global Liraglutide Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 55. Global Liraglutide Percentage 2020-2031: Online Sales VS Offline Sales
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232